Literature DB >> 14740873

Evaluation of the Binax NOW ICT test versus polymerase chain reaction and microscopy for the detection of malaria in returned travelers.

Gabriella A Farcas1, Kathleen J Y Zhong, Fiona E Lovegrove, Christopher M Graham, Kevin C Kain.   

Abstract

Microscopic detection of Plasmodium species has been the reference standard for the diagnosis of malaria for more than a century. However, maintaining a sufficient level of expertise in microscopic diagnosis can be challenging, particularly in non-endemic countries. The objective of this study was to compare a new rapid malaria diagnostic device (NOW ICT Malaria Test; Binax, Inc., Portland, ME) to polymerase chain reaction (PCR) and expert microscopy for the diagnosis of malaria in 256 febrile returned travelers. Compared with PCR, the NOW ICT test showed a sensitivity of 94% for the detection of P. falciparum malaria (96% for pure P. falciparum infection) and 84% for non-P. falciparum infections (87% for pure P. vivax infections and 62% for pure P. ovale and P. malariae infections), with an overall specificity of 99%. The Binax NOW ICT may represent a useful adjunct for the diagnosis of P. falciparum and P. vivax malaria in febrile returned travelers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14740873

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  53 in total

1.  Performance of BinaxNOW for diagnosis of malaria in a U.S. hospital.

Authors:  Michael A Dimaio; Irma T Pereira; Tracy I George; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2012-06-20       Impact factor: 5.948

2.  Malaria diagnosis by NOW ICT and expert microscopy in comparison with multiplex polymerase chain reaction in febrile returned travellers.

Authors:  J Cuadros; P Martín-Rabadán; F J Merino; A Delgado-Irribarren; S Garcia-Bujalance; J M Rubio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-09       Impact factor: 3.267

Review 3.  Malaria in Children.

Authors:  Lauren M Cohee; Miriam K Laufer
Journal:  Pediatr Clin North Am       Date:  2017-08       Impact factor: 3.278

4.  Development of clinical immunity to malaria in highland areas of low and unstable transmission.

Authors:  Melissa A Rolfes; Matthew McCarra; Ng'wena G Magak; Kacey C Ernst; Arlene E Dent; Kim A Lindblade; Chandy C John
Journal:  Am J Trop Med Hyg       Date:  2012-09-17       Impact factor: 2.345

Review 5.  Update on rapid diagnostic testing for malaria.

Authors:  Clinton K Murray; Robert A Gasser; Alan J Magill; R Scott Miller
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

6.  Evaluation of a rapid diagnostic test (CareStart Malaria HRP-2/pLDH (Pf/pan) Combo Test) for the diagnosis of malaria in a reference setting.

Authors:  Jessica Maltha; Philippe Gillet; Emmanuel Bottieau; Lieselotte Cnops; Marjan van Esbroeck; Jan Jacobs
Journal:  Malar J       Date:  2010-06-18       Impact factor: 2.979

7.  Test characteristics of the SD FK80 Plasmodium falciparum/Plasmodium vivax malaria rapid diagnostic test in a non-endemic setting.

Authors:  Philippe Gillet; David P J van Dijk; Emmanuel Bottieau; Lieselotte Cnops; Marjan Van Esbroeck; Jan Jacobs
Journal:  Malar J       Date:  2009-11-22       Impact factor: 2.979

8.  Assessment of the prozone effect in malaria rapid diagnostic tests.

Authors:  Philippe Gillet; Marcella Mori; Marjan Van Esbroeck; Jef Van den Ende; Jan Jacobs
Journal:  Malar J       Date:  2009-11-30       Impact factor: 2.979

9.  Multiplex real-time quantitative PCR, microscopy and rapid diagnostic immuno-chromatographic tests for the detection of Plasmodium spp: performance, limit of detection analysis and quality assurance.

Authors:  Krishna Khairnar; Donald Martin; Rachel Lau; Filip Ralevski; Dylan R Pillai
Journal:  Malar J       Date:  2009-12-09       Impact factor: 2.979

10.  Comparison of different methods for delayed post-mortem diagnosis of falciparum malaria.

Authors:  Nicole Berens-Riha; Inga Sinicina; Erna Fleischmann; Thomas Löscher
Journal:  Malar J       Date:  2009-10-28       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.